120 related articles for article (PubMed ID: 7349809)
1. Urinary alpha-naphthyl acetate esterases: a preliminary screening test for bladder cancer.
El-Sewedy SM; Arafa AM; Mostafa MH; El-Zoghby SM
Cancer Detect Prev; 1981; 4(1-4):455-9. PubMed ID: 7349809
[TBL] [Abstract][Full Text] [Related]
2. The activities of urinary alpha-esterases in bilharziasis and their possible role in the diagnosis of bilharzial bladder cancer in Egypt.
el-Sewedy SM; Arafa A; Abdel-Aal G; Mostafa MH
Trans R Soc Trop Med Hyg; 1978; 72(5):525-8. PubMed ID: 726000
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
4. Urinary lactic dehydrogenase activity as a diagnostic test for detection of bilharzial bladder cancer.
Wassef SA; Abdel Sayed W; Mohran Y; Bassily S; Abdel Ghaffar Y
J Egypt Med Assoc; 1969 Apr; 52(4):274-83. PubMed ID: 5397618
[No Abstract] [Full Text] [Related]
5. The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.
el-Ahmady O; Halim AB; el-Din AG
Anticancer Res; 1999; 19(4A):2603-8. PubMed ID: 10470202
[TBL] [Abstract][Full Text] [Related]
6. Urinary leucine aminopeptidase in bilharziasis.
Khafagy EZ; El-Hawary MF; Galal AF; Salah MK; Shoeb ZM; Ibrahim KB; Omar S
Egypt J Bilharz; 1976; 3(2):199-212. PubMed ID: 1032292
[TBL] [Abstract][Full Text] [Related]
7. Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer.
Koçak H; Oner-Iyidoğan Y; Koçak T; Oner P
Clin Biochem; 2004 Aug; 37(8):673-8. PubMed ID: 15302609
[TBL] [Abstract][Full Text] [Related]
8. Leucine aminopeptidase, Significance of serum elevation in bilharziasis.
Khafagy EZ; El-Hawary MF; Galal AF; Salah MK; Shoeb SM; Ibrahim KB; Omar S
Egypt J Bilharz; 1976; 3(2):183-97. PubMed ID: 1032291
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer.
Chang YH; Wu CH; Lee YL; Huang PH; Kao YL; Shiau MY
Urology; 2004 Oct; 64(4):687-92. PubMed ID: 15491702
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer.
Sánchez-Carbayo M; Urrutia M; González de Buitrago JM; Navajo JA
Clin Cancer Res; 2000 Sep; 6(9):3585-94. PubMed ID: 10999749
[TBL] [Abstract][Full Text] [Related]
11. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
[TBL] [Abstract][Full Text] [Related]
12. BTA-TRAK--a useful diagnostic tool in urinary bladder cancer?
Mahnert B; Tauber S; Kriegmair M; Schmitt UM; Hasholzner U; Reiter W; Hofmann K; Schmeller N; Stieber P
Anticancer Res; 1999; 19(4A):2615-9. PubMed ID: 10470204
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of urinary basic fetoprotein and the BTA test for detection of bladder cancer].
Imamura M; Inoue K; Megumi Y; Nishimura M; Ohmori K; Nishimura K
Hinyokika Kiyo; 2000 Oct; 46(10):705-9. PubMed ID: 11215195
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.
Giannopoulos A; Manousakas T; Gounari A; Constantinides C; Choremi-Papadopoulou H; Dimopoulos C
J Urol; 2001 Aug; 166(2):470-5. PubMed ID: 11458049
[TBL] [Abstract][Full Text] [Related]
15. HER2/neu expression in bladder cancer: relationship to cell cycle kinetics.
Eissa S; Ali HS; Al Tonsi AH; Zaglol A; El Ahmady O
Clin Biochem; 2005 Feb; 38(2):142-8. PubMed ID: 15642276
[TBL] [Abstract][Full Text] [Related]
16. Chronologic changes of activities of naphthol AS-D acetate esterase and other nonspecific esterases in the mononuclear phagocytes of tuberculous lesions.
Tsuda T; Ando M; Shima K; Sugimoto M; Onizuka O; Tokuomi H
Am J Pathol; 1979 Nov; 97(2):235-46. PubMed ID: 118673
[TBL] [Abstract][Full Text] [Related]
17. Acid phosphatase and non-specific alpha-naphthol acetate esterase activities of monocytes in patients with cancer of the digestive tract during surgical treatment.
Merkiel K; Prokopowicz J; Krawczuk J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(3):366-72. PubMed ID: 6194069
[TBL] [Abstract][Full Text] [Related]
18. NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer.
Zippe C; Pandrangi L; Agarwal A
J Urol; 1999 Jan; 161(1):62-5. PubMed ID: 10037369
[TBL] [Abstract][Full Text] [Related]
19. Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer.
Sánchez-Carbayo M; Urrutia M; Silva JM; Romaní R; De Buitrago JM; Navajo JA
J Urol; 2001 May; 165(5):1462-7. PubMed ID: 11342897
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of bladder cancer by analysis of urinary fibronectin.
Menéndez V; Fernández-Suárez A; Galán JA; Pérez M; García-López F
Urology; 2005 Feb; 65(2):284-9. PubMed ID: 15708039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
